The Commonly Used PI3-Kinase Probe LY294002 Is an Inhibitor of BET Bromodomains-Reference-Cited by-同舟云学术

The Commonly Used PI3-Kinase Probe LY294002 Is an Inhibitor of BET Bromodomains

Published:2013-12-10 Issue:2 Volume:9 Page:495-502
ISSN:1554-8929
Container-title:ACS Chemical Biology
language:en
Short-container-title:ACS Chem. Biol.

Author:

Dittmann Antje¹,Werner Thilo¹,Chung Chun-Wa²,Savitski Mikhail M.¹,Fälth Savitski Maria¹,Grandi Paola¹,Hopf Carsten¹,Lindon Matthew³,Neubauer Gitte¹,Prinjha Rabinder K.³,Bantscheff Marcus¹,Drewes Gerard¹

Affiliation:

1. Cellzome GmbH, Meyerhofstrasse 1, 69117 Heidelberg, Germany

2. Molecular Discovery Research, GlaxoSmithKline Medicines Research Centre, Stevenage SG1 2NY, United Kingdom

3. Epinova DPU, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY, United Kingdom

Publisher

American Chemical Society (ACS)

Subject

Molecular Medicine,General Medicine,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/cb400789e

Reference36 articles.

1. Open access chemical and clinical probes to support drug discovery

2. Target validation using chemical probes

3. Analysis of drug-induced effect patterns to link structure and side effects of medicines

4. Target profiling of small molecules by chemical proteomics

5. Chemoproteomic approaches to drug target identification and drug profiling

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A class I PI3K signalling network regulates primary cilia disassembly in normal physiology and disease;Nature Communications;2024-08-21

2. Mannose receptor (MRC1) mediates uptake of dextran in macrophages via receptor-mediated endocytosis;2024-08-13

3. PI3 kinase inhibitor PI828 uncouples aminergic GPCRs and Ca2+ mobilization irrespectively of its primary target;Biochimica et Biophysica Acta (BBA) - General Subjects;2024-08

4. Advancements in dual-target inhibitors of PI3K for tumor therapy: Clinical progress, development strategies, prospects;European Journal of Medicinal Chemistry;2024-02

5. PI3 kinase inhibitor PI828 uncouples aminergic GPCRs and Ca²⁺mobilization irrespectively of its primary target;2024-01-20